Oncogene - Table of Contents alert Volume 37 Issue 42

TABLE OF CONTENTS Volume 37, Issue 42 In this issue Review Article Article Brief Communications Also new AOP Review Article The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein–protein interactions KL Pennington, TY Chan, MP Torres & JL Andersen Oncogene 2018 37 :5587 - 5604; June 18, 2018; 10.1038/s41388-018-0348-3 Abstract | Full Text Article hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis Francesca Di Modugno, Sheila Spada, Belinda Palermo, Paolo Visca, Pierluigi Iapicca et al. Oncogene 2018 37 :5605 - 5617; June 15, 2018; 10.1038/s41388-018-0364-3 Abstract | Full Text miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways Weijun Su, Lixin Hong, Xin Xu, Shan Huang, Denise Herpai et al. Oncogene 2018 37 :5618 - 5632; June 15, 2018; 10.1038/s41388-018-0358-1 Abstract | Full Text Targeting PRPK and TOPK for skin cancer prevention and therapy Eunmiri Roh, Mee-Hyun Lee, Tatyana A. Zykova, Feng Zhu, Janos Nadas et al. Oncogene 2018 37 :5633 - 5647; June 14, 2018; 10.1038/s41388-018-0350-9 Abstract | Full Text O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1 Chatchai Phoomak, Atit Silsirivanit, Dayoung Park, Kanlayanee Sawanyawisuth, Kulthida Vaeteewoottacharn et al. Oncogene 2018 37 :5648 - 5665; June 18, 2018; 10.1038/s41388-018-0366-1 Abstract | Full Text Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism Mingzhu Bai, Linlin Yang, Hong Liao, Xiaoyan Liang, Bingying Xie et al. Oncogene 2018 37 :5666 - 5681; June 19, 2018; 10.1038/s41388-018-0360-7 Abstract | Full Text Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer Kristina Golfmann, Lydia Meder, Mirjam Koker, Caroline Volz, Sven Borchmann et al. Oncogene 2018 37 :5682 - 5693; July 03, 2018; 10.1038/s41388-018-0380-3 Abstract | Full Text Brief Communications Massive expression of germ cell-specific genes is a hallmark of cancer and a potential target for novel treatment development Jan Willem Bruggeman, Jan Koster, Paul Lodder, Sjoerd Repping & Geert Hamer Oncogene 2018 37 :5694 - 5700; June 15, 2018; 10.1038/s41388-018-0357-2 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. This email has been sent to edgeblog.alerts.2011.001@gmail.com. If you no longer wish to receive the email alerts from Oncogene click here to unsubscribe . If you wish to discontinue all email services from Nature Research please click here to unsubscribe . For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.